Delivery Order SPE2DB20D3505-SPE2DB24FU5E1

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,708.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,003.00, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. The contract provides for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,358.56, is a delivery order for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024 and is a firm fixed-price contract. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of June 3, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,741.68 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $3,593.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor and has no set-aside designation for this award. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal...
This federal contract award, valued at $3,430.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024 and does not have a set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor in the United States, has been awarded numerous federal contracts to...
This federal contract award, valued at $13,489.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,306.26 fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a completion date of June 20, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award for $73,716.00 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has no set-aside designation and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU5E1
    Delivery Order

This federal contract award, valued at $2,612.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product "TRULICITY 3 MG/0.5 ML PEN 0.5ML" and does not have a set-aside designation.

AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, AmerisourceBergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/25/24, 9:19 AM